Diabetes-associated metabolic-immune signature stratifies survival and immunotherapy response in pancreatic adenocarcinoma through multi-omics integration
Authors:
- Le TangLTLe Tang
- Mengwei YangMYMengwei Yang
- Tongji XieTXTongji Xie
- Guangyu FanGFGuangyu Fan
- Haohua ZhuHZHaohua Zhu
- Jiari YaoJYJiari Yao
- Xiaohong HanXHXiaohong Han
- Yuankai ShiYSYuankai Shi
Open Access
- 1 February 2026
- journal article
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 4 (1) , 126-138
Abstract
No abstract availableFunding Information
- National Science and Technology Major Project
- National Major Science and Technology Projects of China (2017ZX09304015)
This publication has 56 references indexed in Scilit:
- Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spacesCell Systems, 2023
- Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancerJournal of Cancer Research and Clinical Oncology, 2020
- Challenges and Opportunities for Pancreatic Cancer ImmunotherapyCancer Cell, 2020
- Immunotherapy for pancreatic cancer: A 2020 updateCancer Treatment Reviews, 2020
- The intricate relationship between diabetes, obesity and pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinomaEBioMedicine, 2019
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint BlockadeCell Reports, 2017
- Atg7 in development and disease: panacea or Pandora’s Box?Protein & Cell, 2015
- The putative tumor suppressor Zc3h12d modulates toll-like receptor signaling in macrophagesCellular Signalling, 2012
- SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cellsBreast Cancer Research and Treatment, 2009